9
Views
2
CrossRef citations to date
0
Altmetric
CaseReport Article

Neuroleptic malignant syndrome: two cases without muscle rigidity

Pages 415-418 | Published online: 11 May 2010

References

  • Delay J, Deniker P. Drug-induced extrapyramidal syndrome. Handbook of clinical neurology. New York: Elsevier, PJ Visken, GW Bruyn, 1968; 248–266
  • Gurrera RJ, Chang SS, Romero JA. A comparision of diagnostic criteria for neuroleptic malignant syndrome. Journal of Clinical Psychiatry 1992; 53: 56–62
  • Smego RA, Durack DT. The neuroleptic malignant syndrome. Archives of Internal Medicine 1982; 142: 1183–1185
  • Shalev A, Munitz H. The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatrica Scandinavica 1986; 73: 337–347
  • Lavie CJ, Olmsted TR, Ventura HO. Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents? Postgraduate Medicine 1986; 80: 171–178
  • Addonizio G, Susman VL, Roth SD. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. American Journal of Psychiatry 1986; 143: 1587–1590
  • Rosebush P, Stewart T. A prospective analysis of 24 episodes of neuroleptic malignant syndrome. American Journal of Psychiatry 1989; 146: 717–725
  • Caroff SN. The neuroleptic malignant syndrome. Journal of Clinical Psychiatry 1982; 41: 79–83
  • Zubenko D, Pope HG. Management of a case of neuroleptic malignant syndrome with bromocriptine. American Journal of Psychiatry 1983; 140: 1619–1620
  • Sternberg DE. Neuroleptic malignant syndrome: the pendulum swings. American Journal of Psychiatry 1986; 143: 1273–1275
  • Langstone JW, Forno LS. The hypothalamus in Parkinson's disease. Annual of Neurology 1978; 3: 129–133
  • Henderson VW, Wooten GF. Neuroleptic malignant syndrome: a pathogenic role for dopamine receptor blockade?. Neurology 1981; 31: 132–137
  • Downey GP, Caroff S, Rosenberg H, Gerber JC, Heiman-Patterson TD, Aronson MD. Neuroleptic malignant syndrome. Patient with unique clinical and physiologic features. American Journal of Medicine 1984; 77: 338–340
  • Misiaszek JJ, Potter RL. Atypical neuroleptic malignant syndrome responsive to conservative management. Psychosomatics 1985; 26: 62–66
  • Conlon P. The spectrum concept of neuroleptic toxicity. American Journal of Psychiatry 1986; 143: 811
  • Pope HG, Keck PE, McElory SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. American Journal of Psychiatry 1986; 143: 1227–1233
  • Guze BH, Baxter LR. Current concept: neuroleptic malignant syndrome. New England Journal of Medicine 1985; 313: 163–166
  • Burke RE, Fahn S, Mayeux R. Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington's disease. Neurology 1981; 31: 1022–1026
  • Simpson DM, Davis GC. Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine. American Journal of Psychiatry 1984; 141: 796–797
  • Friedman JH, Feinberg SS, Feldman RG. A neuroleptic malignant-like syndrome due to levodopa therapy withdrawal. Journal of the American Medical Association 1985; 254: 2792
  • Fogel BS, Goldberg RJ. Neuroleptic malignant syndrome. New England Journal of Medicine 1985; 313: 1292

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.